Filing Details

Accession Number:
0001171843-14-000111
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-01-09 17:05:47
Reporting Period:
2014-01-07
Filing Date:
2014-01-09
Accepted Time:
2014-01-09 17:05:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1365216 Sucampo Pharmaceuticals Inc. SCMP Pharmaceutical Preparations (2834) 133929237
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1370930 J Cary Claiborne 4520 East West Hwy, 3Rd Floor
Bethesda MD 20814
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-01-07 2,400 $4.41 2,400 No 4 M Direct
Common Stock Acquisiton 2014-01-07 100 $4.07 2,500 No 4 M Direct
Common Stock Disposition 2014-01-07 2,500 $9.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2014-01-07 2,400 $0.00 2,400 $4.41
Common Stock Employee Stock Option (right to buy) Disposition 2014-01-07 100 $0.00 100 $4.07
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
105,560 2013-06-04 2021-05-02 No 4 M Direct
105,460 2013-06-04 2021-10-17 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were realized pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2013.